InvestorsHub Logo
icon url

Atom0aks

11/21/19 2:45 PM

#229295 RE: sts66 #229268

No statins have patent protection left except Kowa's Livalo, so no need for AMRN to license a statin patent from anyone. Otherwise, you're correct - GILD wanting to combine V with another drug would require them licensing rights from AMRN - would also extend protection from generic V for that combo use.



Oh! I forgot about that! Good catch :D